Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hertenstein

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Deutsche Medizinische Wochenschrift (1946)|January 8, 1988
[Bone marrow transplantation as therapy in chronic myeloid leukemia]T Schmeiser, R Arnold, M Wiesneth, et al.
European Journal of Haematology|August 4, 1998
Chronic myeloid leukemia in accelerated phase: treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patientsM Griesshammer, R Arnold, M Bangerter, et al.
Bone Marrow Transplantation|September 1, 1993
Graft rejection by a population of primed CDw52- host T cells after in vivo/ex vivo T-depleted bone marrow transplantationD Bunjes, M Theobald, M Wiesneth, et al.
Klinische Wochenschrift|October 15, 1987
Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantationT Schmeiser, W Heit, R Arnold, et al.
Bone Marrow Transplantation|November 13, 2001
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemiaL Hambach, M Eder, E Dammann, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|June 1, 1992
[Phases in the rehabilitation of male and female bone marrow transplant patients]R Arnold, P Bergerhoff, R Denzinger, et al.
Bone Marrow Transplantation|January 1, 1993
In vitro and in vivo depletion of T cellsR Arnold, D Bunjes, M Wiesneth, et al.
Transplantation|November 1, 1993
Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantationB Hertenstein, M Wiesneth, J Novotny, et al.
Bone Marrow Transplantation|March 1, 1995
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMTB Hertenstein, W Hampl, D Bunjes, et al.
Journal of Hematotherapy & Stem Cell Research|January 19, 2002
Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantationW H Krüger, R J Hornung, B Hertenstein, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Deutsche Medizinische Wochenschrift (1946)|January 8, 1988
[Bone marrow transplantation as therapy in chronic myeloid leukemia]T Schmeiser, R Arnold, M Wiesneth, et al.
European Journal of Haematology|August 4, 1998
Chronic myeloid leukemia in accelerated phase: treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patientsM Griesshammer, R Arnold, M Bangerter, et al.
Bone Marrow Transplantation|September 1, 1993
Graft rejection by a population of primed CDw52- host T cells after in vivo/ex vivo T-depleted bone marrow transplantationD Bunjes, M Theobald, M Wiesneth, et al.
Klinische Wochenschrift|October 15, 1987
Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantationT Schmeiser, W Heit, R Arnold, et al.
Bone Marrow Transplantation|November 13, 2001
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemiaL Hambach, M Eder, E Dammann, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|June 1, 1992
[Phases in the rehabilitation of male and female bone marrow transplant patients]R Arnold, P Bergerhoff, R Denzinger, et al.
Bone Marrow Transplantation|January 1, 1993
In vitro and in vivo depletion of T cellsR Arnold, D Bunjes, M Wiesneth, et al.
Transplantation|November 1, 1993
Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantationB Hertenstein, M Wiesneth, J Novotny, et al.
Bone Marrow Transplantation|March 1, 1995
In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMTB Hertenstein, W Hampl, D Bunjes, et al.
Journal of Hematotherapy & Stem Cell Research|January 19, 2002
Practices of infectious disease prevention and management during hematopoietic stem cell transplantation: a survey from the European group for blood and marrow transplantationW H Krüger, R J Hornung, B Hertenstein, et al.
Pageof 11